secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kura Oncology, Inc. (KURA)
CIK:        0001422143
Form:       8-K
Filed at:   2025-10-16T23:59:59+00:00
Accession:  0001193125-25-241416
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kura Oncology increases inducement stock option plan by 750,000 shares to 3.25M total
--------------------------------------------------------------------------------

- Board approved amendment to 2023 Inducement Option Plan, adding 750,000 shares for total of 3,250,000 shares.
- Plan reserved exclusively for nonstatutory stock options to new employees as inducement material to hire.
- Amendment approved without stockholder approval per Nasdaq Rule 5635(c)(4).
- Plan administered by independent directors or independent compensation committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1422143/000119312525241416/0001193125-25-241416-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1422143/000119312525241416/d20988d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-241416

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer